RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)

Clinical trial NCT06684964 · RECRUITING

Trial details

NCT number: NCT06684964
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Myelogenous Leukemia in Chronic Phase

Start date: 2025-03-24
Primary completion: 2026-12-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.